Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy?

IBBQ's concentrated biotech play has delivered a higher one-year return, while IXJ'S diversified global healthcare fund has been much less volatile.

IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy?

Published July 18, 2026 · Category: Finance

Overview

The iShares Global Healthcare ETF (NYSEMKT:IXJ) provides broad, established exposure to global healthcare giants, while the Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) offers a lower-cost concentrated bet on biotechnology.

Both funds give investors exposure to the healthcare sector. But while IXJ tracks a global index of healthcare stocks spanning multiple sub-industries, IBBQ zeroes in on biotech and pharma names listed on the Nasdaq.

Details

Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-year return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.